WEKO3
-
RootNode
アイテム
教室における肝細胞癌治療の変遷と予後の検討
http://hdl.handle.net/10422/103
http://hdl.handle.net/10422/1038cca31a8-8456-44c0-bdb0-d7b061929933
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
jsums15p037.pdf (1.4 MB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2016-04-12 | |||||
| タイトル | ||||||
| タイトル | 教室における肝細胞癌治療の変遷と予後の検討 | |||||
| 言語 | ja | |||||
| タイトル | ||||||
| タイトル | Change of treatments for hepatocellular carcinoma and it's prognosis | |||||
| 言語 | en | |||||
| タイトル | ||||||
| タイトル | キョウシツ ニ オケル カンサイボウ ガン チリョウ ノ ヘンセン ト ヨゴ ノ ケントウ | |||||
| 言語 | ja-Kana | |||||
| 言語 | ||||||
| 言語 | jpn | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | departmental bulletin paper | |||||
| アクセス権 | ||||||
| アクセス権 | open access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
| 著者 |
来見, 良誠
× 来見, 良誠× 花澤, 一芳× 仲, 成幸× 谷, 徹× 小玉, 正智× 石塚, 義之× 馬場, 忠雄× 岡部, 英俊 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | One hundred thirty-four patients with hepatocellular carcinoma (HCC) were treated in our department. Hepatic resection was performed in 78 patients with HCC. According to the development of medical instruments, indication for hepatic resection has changed. Intraoperative hepatic ultrasonography provides a great deal of information about tumor location and vascular anatomy in the liver, and is an indispensable procedure for hepatic resection. Vascular surgery techniques are being increasingly applied in our department for the treatment of HCC. Hepatic vascular exclusion can be performed safely using a centrifugal active pump, even in the patients with cirrhosis. To reduce post-hepatectomy liver failure, an accurate preoperative assessment of hepatic functional reserve is essential. The indocyanine green test has been used conventionally. It is useful to decide the resected line of the liver. The survival rates after hepatectomy for hepatocellular carcinoma according to cancer stage were reported. The 5-year survival rates of Stages I, II, III and IV were 66.7%, 59.0%, 45.1%, and 24.0%, respectively. These survival rates were nearly equal to those reported in the results of a survey and follow-up study of primary liver cancer in Japan. | |||||
| 言語 | en | |||||
| 書誌情報 |
ja : 滋賀医科大学雑誌 巻 15, p. 37-41, 発行日 2000-02 |
|||||
| 出版者 | ||||||
| 出版者 | 滋賀医科大学雑誌刊行会 | |||||
| 言語 | ja | |||||
| NCID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN10044327 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
